CANVA
30.7.2024 05:31:28 CEST | Business Wire | Press release
Canva, a world leader in visual communication with more than 190 million monthly active users, today announced plans to acquire Leonardo.AI. As one of Australia’s fastest-growing startups, and a leading generative AI content and research company, Leonardo.AI is empowering millions of people to bring their ideas to life through production-quality images and videos. The acquisition complements Canva's offering and enhances the company’s vision to build a world-class suite of visual AI tools, marking this as an important milestone in its AI journey.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729977410/en/
Canva will acquire Leonardo.AI, a leading generative AI content and research company (Graphic: Business Wire)
As AI continues to shape the future of work and visual communication, the acquisition will accelerate Canva’s investment in continued research and development while bringing Leonardo’s cutting-edge foundational model to Canva’s community worldwide. From creating assets for marketing and advertising campaigns, to visualizing stunning interior concepts, refining mockups, and producing dynamic videos, Leonardo’s technology has been used to produce more than one billion images in the last 18 months.
For Leonardo.AI this is an opportunity to produce new levels of AI innovation while also growing the organisation’s scale. With Canva’s support, the company’s current trajectory will be supercharged to build an even more creative-centric generative AI platform globally.
“We’re thrilled to welcome Leonardo.AI to Canva - two Australian companies joining forces to bring world-first breakthroughs in AI and creativity," said Cameron Adams, co-founder and Chief Product Officer of Canva. “This field is constantly evolving, and Leonardo’s technical leadership and community impact can’t be overstated. Bringing our worlds together will accelerate each of our teams' work, taking us from strength to strength, and we can’t wait to get started.”
World Leading Generative AI Capabilities
Founded in late 2022, Leonardo’s foundational model empowers millions of people to turn ideas into production-quality visual assets with unprecedented control, speed and style consistency. Creators can generate images in any chosen aesthetic in seconds with simple prompts, create videos, sketch with AI, and custom-train models with their own datasets.
Leonardo's new foundational model, Phoenix, takes creator control to the next level, with unprecedented prompt adherence, coherent, accurate text in images and the ability to generate production-ready assets in one shot.
“Today marks the start of a new chapter which will accelerate the pace we innovate at Leonardo.Ai,” said JJ Fiasson, Founder and CEO, Leonardo.AI. Joining the Canva family means we can invest more deeply in scaling our AI research efforts globally, and move even faster to deliver new features and functionality to creatives worldwide.”
In less than two years since launching, Leonardo.AI has amassed more than 19 million registered users and is used across a wide variety of industries including advertising, marketing, design, entertainment, architecture, fashion, e-commerce and education. The joint effort with Canva will produce new levels of AI technology to not only engage, but to also grow Leonardo’s fast growing user base.
From hobbyists to film directors, architects, and professional designers, Leonardo’s technology delivers advanced creative control that pushes the boundaries of what’s possible in generative AI, while remaining intuitive and accessible. Its models can generate stunning images in styles ranging from strikingly realistic photos to character portraits, anime, painterly styles, and more, while its AI video generation tools can bring almost any concept to dynamic life.
Reimagining Visual Communication
Canva’s recent Visual Economy Report shows that the need for effective, efficient, and compelling visual communication has surged dramatically. AI is now playing an increasingly important role in elevating both productivity and creativity at work. From marketing teams scaling global campaigns by instantly generating ad creative for specific audiences, to designers creating initial drafts and storyboards, generative artificial intelligence is changing the way work gets done.
Leonardo’s world-class technology and foundational model will supercharge Canva’s mission to empower every kind of professional to turn their ideas into designs in an instant, leading to faster, more innovative, and more compelling visual communication.
Leonardo's technology will complement Canva’s Magic Studio, the company’s suite of AI tools, which has been used more than 7 billion times since it launched in 2023. To date, Canva users have elevated their design and creative output leveraging Magic Studio for everything from summarising documents to creating images and turning brainstorm whiteboards into fully-fledged presentations.
Supercharging Canva’s AI Journey
Canva will continue to invest in Leonardo's standalone platform while integrating its technology throughout the company’s suite of Magic Studio products. Working with Leonardo’s team of 120 high-caliber researchers, engineers, and designers will also bolster Canva’s research and development capabilities as the company continues to invest in long-term innovation opportunities.
Acquisitions have played an important role in elevating and accelerating Canva’s technology over the last decade. The acquisition of Leonardo is the company’s 8th acquisition, joining Affinity (2024), Flourish (2022), Kaleido (2021), Smartmockups (2021), Pexels (2019), Pixabay (2019) and Zeetings (2018).
For more details about the acquisition, see Canva Co-Founder Cameron Adams blog post and Leonardo.Ai’s CEO JJ Fiasson’s blog post, respectively.
About Canva
Launched in 2013, Canva is a free online visual communications and collaboration platform with a mission to empower everyone in the world to design. Featuring a simple drag-and-drop user interface and a vast range of templates ranging from presentations, documents, websites, social media graphics, posters, apparel to videos, plus a huge library of fonts, stock photography, illustrations, video footage, and audio clips, anyone can take an idea and create something beautiful.
About Leonardo.Ai
Leonardo.Ai is one of Australia’s fastest-growing startups, democratising creativity with its generative AI content production platform. Since launching in 2022, the company has amassed more than 19 million users worldwide, who have generated over one billion images. Leonardo.Ai is currently being used by both hobbyists and professionals across creative industries such as advertising and marketing, design and architecture, film, fashion, photography, e-commerce, education, and more.
Downloadable Assets
Click here
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240729977410/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom